The purpose of this AUS is to evaluate the extent to which participants can safely and
effectively self-select, purchase, and use Crestor OTC 5 mg for a 6-month period according to
This is a single-arm, interventional, phase III Self-Selection (SS) and Actual Use Study
(AUS) using a technology assisted tool within a Web App. The open-label study will enroll
approximately 1220 participants who qualify for treatment based on the data they enter into
the Web App of which an estimated 1000 participants will ultimately proceed to the use phase.
5 mg rosuvastatin calcium with a Web App (combination product)
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.